5-Fluorocytosine resistance in candida spp. and Torulopsis glabrata.
D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects* / Q000302:isolation & purification; D002176:Candida albicans / Q000302:isolation & purification; D002177:Candidiasis / Q000382:microbiology; D003453:Cryptococcosis / Q000382:microbiology; D003596:Cytosine / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D005260:Female; D005437:Flucytosine / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008172:Lung Diseases, Fungal / Q000382:microbiology; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D003904:Mitosporic Fungi / Q000187:drug effects*; D010608:Pharyngeal Diseases / Q000382:microbiology; D014552:Urinary Tract Infections / Q000382:microbiology
D000935:Antifungal Agents; D003596:Cytosine; D005437:Flucytosine